Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Amador Bioscience Nabs $60M Series B+ Round

2021-12-30
PLEASANTON, CA, Amador Bioscience, a global translational sciences and clinical pharmacology CRO, has raised a $60 million Series B+ financing.
The round was led by MSA Capital, a global private equity firm. Other participating investors include Series B Co-leads GL Ventures (venture capital arm of Hillhouse Group) and Sequoia Capital, and Series A lead VC Co-win Ventures.

Amador Bioscience, a leading partner for successful new drug development, provides global-standard translational sciences and clinical pharmacology services to clients ranging from cutting-edge biotech start-ups to multinational pharmaceutical companies.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors